Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow Stem Cell Therapy Combined With Psychological Therapy and Rehabilitation for Autism
NCT03225651Phase 2Completed
- Sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology
- Start
- Jul 2017
- Primary completion
- Aug 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in Autism Spectrum Disorder (ASD), sponsored by Vinmec Research Institute of Stem Cell and Gene Technology. Started Jul 2017; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03225651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03225651.